Phase 2 study demonstrates that a new blood plasma Alzheimer biomarker may assist in earlier diagnosis of Alzheimer’s disease

Dr. Barry Dworkin

Medical Mythbusting Commentary for April 26, 2022

Phase 2 study demonstrates that a new blood plasma Alzheimer biomarker may assist in earlier diagnosis of Alzheimer's disease Play Now | Play in Popup | Download

Source:
New Alzheimer’s Biomarker May Facilitate Rapid Diagnosis

Reference:
A possible blood plasma biomarker for early-stage Alzheimer’s disease

Related posts:

  1. ASA does not prevent Alzheimer Disease
  2. Combination of imaging and neurocognitive testing in elderly with mild cognitive impairment helps predict risk of Alzheimer's within two years of screening
  3. Retinal eye exam study for the early detection of Alzheimer’s has his limitations and requires larger study populations to evaluate whether this is an effective screening test
  4. Ketogenic drink may help curb mild cognitive impairment due to Alzheimer’s disease but then again it may not. Only 52 people involved in this small study.
Bitnami